I-Mab Site 1013 — Sugarland, Texas

I-Mab Site 1013 is a clinical research site located in Sugarland, Texas, United States 77479.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

I-Mab Site 1013 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Solid Tumor, Advanced Cancer, Metastatic Cancer.

Sponsors: I-Mab Biopharma US Limited.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for I-Mab Site 1013?

I-Mab Site 1013 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has I-Mab Site 1013 conducted?

I-Mab Site 1013 has 1 clinical trials on record, with 1 currently active. Their work covers Solid Tumor, Advanced Cancer, Metastatic Cancer.

Is I-Mab Site 1013 accredited by Crixeo Health?

I-Mab Site 1013 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about I-Mab Site 1013?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.